Advancis Pharmacautical enters marketing agreement with Innovex

Advancis Pharmaceutical Corporation has entered into a two-year sales and marketing agreement with Innovex for 75 sales reps to promote Advancis' recently approved cephalosporin antibiotic Keflex (cephalexin). Promotion of Keflex was scheduled to begin in mid-July.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions